MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 140 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6,164 | -45.0% | 22 | -47.6% | 0.00% | -100.0% |
| Q1 2024 | $11,216 | +120.3% | 42 | +90.9% | 0.00% | – |
| Q4 2023 | $5,091 | +168.1% | 22 | +69.2% | 0.00% | – |
| Q3 2023 | $1,899 | -41.3% | 13 | -7.1% | 0.00% | – |
| Q2 2023 | $3,234 | +2.7% | 14 | +7.7% | 0.00% | – |
| Q1 2023 | $3,150 | -74.8% | 13 | -69.8% | 0.00% | -100.0% |
| Q4 2022 | $12,481 | – | 43 | +1333.3% | 0.00% | – |
| Q2 2022 | $0 | – | 3 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 3 | +200.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 1 | -93.8% | 0.00% | – |
| Q3 2021 | $1,000 | – | 16 | +700.0% | 0.00% | – |
| Q2 2021 | $0 | – | 2 | -33.3% | 0.00% | – |
| Q1 2021 | $0 | – | 3 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 3 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 73,487 | $17,003,422 | 28.29% |
| Tao Capital Management LP | 130,529 | $30,202 | 27.63% |
| Paulson & Co. | 1,105,741 | $255,846,353 | 23.09% |
| AlpInvest Partners B.V. | 211,488 | $48,934,093 | 11.18% |
| Bain Capital Life Sciences Investors, LLC | 324,619 | $75,110,344 | 7.20% |
| Avoro Capital Advisors LLC | 1,888,888 | $437,050,905 | 6.04% |
| Propel Bio Management, LLC | 30,032 | $6,948,804 | 5.76% |
| Baker Brothers Advisors | 1,969,798 | $455,771,861 | 5.19% |
| Rosalind Advisors, Inc. | 25,000 | $5,784,500 | 4.76% |
| TCG Crossover Management, LLC | 179,917 | $41,629,195 | 4.62% |